The open index of psychedelic research

Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders.

Barbieri A

Comment on, "the effect of esketamine as adjuvant to ropivacaine for unilateral paravertebral block on postoperative pain and sensitization in adult patients undergoing video-assisted thoracoscopic surgery: a randomized clinical trial", by Yang et al.

Bilal H, Majeed F, Abbas S +1

Effect of Intravenous Ketamine Combined With Spinal Anesthesia on Sensory Block Duration Compared to Spinal Anesthesia Alone in Lower Limb Surgeries in Geriatrics.

Media hype regarding psychedelic treatments for depression and PTSD from 2017 to 2024.

Evers A, Stade EC, Salecha A +2

Anesthesia management of a child with Melnick-Needles syndrome associated with retrognathia and significant tracheomalacia.

Li X, Chen Y, Zuo Y

Psilocybin for PTSD with or without Psychotherapy: A Pilot study of safety and efficacy outcomes – The first characterization of nightmare burden in PTSD following psilocybin administration

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.

Askey T, Allen-Ross D, Luzyanin D +7

The MDK Study: Using a Combination of Methadone-dexmedetomidine-ketamine for Postoperative Pain Control in Patients Undergoing Complex Spine Surgeries.

The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.

Coerts DT, Smith-Apeldoorn SY, Oude Nijhuis JC +6

Characterising the clinical associations of hallucinogen persisting perception disorder: a retrospective cohort study.

Butler M, Moore E, Rucker JJ +6

The Monoamine-Glutamate Continuum of Depression: A Neurobiological Framework for Precision Psychiatry.

Carmellini P, Cuomo A, Rescalli MB +3

Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depression.

Colizzi M, Morandin E, Croccia V +5

A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice.

Smith-Apeldoorn SY, Veraart JKE, Kamphuis J +1

Beyond Psychedelic Exceptionalism: How People Combine Meditation With Psychoactive Substances and How This Relates to Well-Being

The complete chloroplast genome sequence of <i>Lophophora diffusa</i>.

Zhang T, Li N, Cui Z +2

Variation at <i>COMT, ADH1B-ADH1C</i> and <i>HTR2A</i> is associated with substance use disorders in Ukrainians

Bashynska V, Zahorodnia O, Borysovych Y +12

Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression - A Systematic Review.

Mano-Sousa BJ, Fontes MCG, Gonçalves ACA +2

Brain-body integromics of the ayahuasca experience.

Madrid-Gambin F, Mallaroni P, Haro N +7

Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.

Low ZXB

S-ketamine mitigates paclitaxel-induced pain-related anxiety-like behavior through downregulation of mGluR5 and activation of the BDNF/TrkB signaling pathway.

Cao J, Wang Z, Lv G +8

Study of Midomafetamine in Healthy Adults

Protective effects of vitamin E and quercetin against MDMA-induced cardiac and hematological dysfunction in male wistar rats.

Ajayi AF, Oluwole DT, Hamed MA +5

Recreational Drug Use at a Music Festival: A Dual Approach Using Hair Biomarkers Analysis and Participant Self-Reported Drug Use.

Simão AY, Rosado T, Barroso M +2

Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations

Salinsky LM, Fox JL, Diaz KC +2